Share on StockTwits

Investment analysts at Jefferies Group upped their target price on shares of Aetna (NYSE:AET) from $87.00 to $89.00 in a note issued to investors on Friday, Analyst Ratings.Net reports. Jefferies Group’s price target points to a potential upside of 24.91% from the stock’s previous close.

Aetna (NYSE:AET) opened at 71.25 on Friday. Aetna has a 1-year low of $56.05 and a 1-year high of $76.71. The stock has a 50-day moving average of $72.80 and a 200-day moving average of $68.54. The company has a market cap of $25.842 billion and a price-to-earnings ratio of 13.69.

Aetna (NYSE:AET) last issued its quarterly earnings data on Thursday, April 24th. The company reported $1.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.43. The company had revenue of $13.97 billion for the quarter, compared to the consensus estimate of $13.69 billion. During the same quarter in the previous year, the company posted $1.50 earnings per share. The company’s revenue for the quarter was up 46.9% on a year-over-year basis. Analysts expect that Aetna will post $6.39 EPS for the current fiscal year.

AET has been the subject of a number of other recent research reports. Analysts at Susquehanna raised their price target on shares of Aetna from $80.00 to $85.00 in a research note on Thursday, April 10th. They now have a “positive” rating on the stock. Separately, analysts at Deutsche Bank raised their price target on shares of Aetna from $76.00 to $84.00 in a research note on Thursday, April 3rd. They now have a “buy” rating on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Aetna in a research note on Tuesday, April 1st. They now have a $79.00 price target on the stock. Four research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Aetna currently has an average rating of “Buy” and an average price target of $78.21.

Aetna Inc (NYSE:AET) is a diversified healthcare benefits company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.